Histopathological investigation of wound healing activities of Lucilia sericata Larva and Achillea sintenisii extract combinations in diabetic rat wound model Authors: Nevra Polat, Salih Mollahaliloğlu, Murat Koç Published: 2026 ABSTRACT AbstractChronic wounds, particularly in diabetic patients, represent a major clinical and economic burden on healthcare systems worldwide. Complementary therapies are increasingly integrated alongside conventional treatments to improve healing outcomes. Maggot debridement therapy (MDT), utilizing the larvae of Lucilia sericata, is a globally recognized method for treating non‐healing wounds. These larvae secrete substances with antifungal, antibacterial and anti‐inflammatory properties. Herbal remedies also play a role in chronic wound care, with various Achillea species traditionally used for medicinal purposes. This study investigated the wound healing effects of a pomade combining L. sericata larval secretions and Achillea sintenisii plant extract, compared to Furacin®, a commercial wound healing cream. Excisional wounds were created on diabetic Wistar albino rats, which were divided into four groups: DF (Furacin®), DM (L. sericata secretion), DA (A. sintenisii extract) and DM + DA (combined). Wound area, contraction rates and histological parameters were assessed at Days 0, 4, 8 and 12. Wound area decreased significantly across all groups over time (F = 511.9, p = 0.001), with mean values declining from 11.11 cm2 at Day 0 to 7.44 cm2 at Day 4, 4.93 cm2 at Day 8 and 2.01 cm2 at Day 12. Contraction rates rose progressively across all groups (F = 169.3, p = 0.001): at Day 4, contraction rates were 20.41% ± 1.24% (DF), 43.29% ± 3.96% (DM), 27.67% ± 0.94% (DA) and 42.22% ± 1.20% (DM + DA); at Day 8, rates increased to 42.86% ± 1.11% (DF), 63.34 ± 0.92% (DM), 52.97% ± 0.55% (DA) and 63.26% ± 0.52% (DM + DA) and at Day 12, the DM + DA group achieved the highest contraction rate of 92.91% ± 0.40%, significantly surpassing all other groups—DM (84.30% ± 0.88%), DA (79.43 ± 0.61%) and DF (71.77% ± 0.64%)—demonstrating a clear synergistic effect of the combined therapy (p < 0.05). Histological evaluation further corroborated these findings, with the DM + DA group consistently achieving the highest scores across all tissue repair parameters (epithelialization, fibroblast density, collagen deposition, angiogenesis and hair follicle regeneration), significantly superior to all other groups (p < 0.05). Taken together, these results confirm that the combination of L. sericata secretions and A. sintenisii extract exerts a synergistic wound healing effect superior to either agent alone or to Furacin® and could lead to the development of affordable, accessible and effective natural products for chronic wound care. These results may contribute to innovative treatment options in both veterinary and human medicine.Keywords: Achillea sintenisii, chronic wound, diabetes mellitus, Lucilia sericata, maggot, wound healing INTRODUCTION Healing of skin wounds is a fascinating mechanism and represents an evolutionary advantage. Due to its vital functions as a physical, chemical and microbial defence barrier, skin repair requires complex synchronization of several cell types of the wound in sequential steps. The increasing incidence of non‐healing skin wounds in developed societies, a complex and dynamic cascade of cellular, molecular interactions known as ‘wound healing’, has led to enormous research efforts in the process. While small skin wounds heal within a few days, larger wounds such as diabetic ulcer wounds, trauma, frequent and recurrent wounds, or those resulting from a major operation become chronic and can take a long time to heal. It is important to develop therapeutics with comprehensive knowledge of cellular mechanisms for the repair of such wounds (Kalan & Brennan, 2019), which result in disruption of anatomical functional tissue integrity and leave behind a fibrotic scar that can affect tissue function (Menaa et al., 2013). Diabetes mellitus (DM), a highly complex pathology that threatens the lives of approximately 500 million people today, is predicted to increase in incidence in the future, causing global concern. This huge increase in the morbidity and mortality of diabetes is due to delays in wound healing and the development of macro‐ and micro‐vascular complications. The financial burden, the high psychosocial problems resulting from the negative impact on patients' quality of life and the necessity of amputation necessitate the development of different effective treatment modalities. In this context, scientific research has focused more on traditional medicine products, natural medicines, which have advantages over modern clinical drugs, minimal side effects in unwanted and unexpected situations, low cost, practicality and easy accessibility (Khan & Ahmad, 2019). Plants, plant‐based extracts, bioactive components isolated from plants, minerals (zinc and copper), animals and animal natural resources are among the traditional medicine products discovered to combat this debilitating disease. When we look at today's market, there are many medical wound dressings and topical products under the name of traditional medicine products for the product to be used in clinical practice. It is not preferred because of its impracticality, possible adverse reaction risks, ineffective treatment results and economic additional burden, especially for chronic wounds. Complementary and integrative medicine treatment approaches have recently become the focus of attention in modern medicine. Among these treatment approaches, Maggot (Larva) Debridement Therapy (MDT/LDT) is an effective method used for non‐healing suppurative skin soft tissues, open wounds, gangrene and necrotic tissue, and symptoms associated with mycotic infections (Bazaliński et al., 2019). Four fundamental conditions for wound healing to occur are: elimination of ongoing trauma, control of infection, optimization of vascularization and implementation of effective debridement in necrotic tissues (Thomas et al., 2021). Therefore, although debridement may appear to be a simple procedure, it is considered the primary and most critical step in the treatment of diabetic wounds. The main function of Maggot Debridement Therapy (MDT) is to support the complete elimination of necrotic tissue, which is of great importance for diabetic patients. Maggot excretions/secretions (ES) contain numerous bioactive components, and these provide a synergistic effect in the wound healing process. The enzymes secreted by maggots to facilitate their feeding and thus ensure effective debridement include proteases (metalloproteases such as collagenase and serine, chymotrypsin‐like and trypsin‐like enzymes), lipases, nucleases and glycosidases (Bohova et al., 2012; Tombulturk & Kanigur‐Sultuybek, 2021). There is also increasing evidence that maggot secretions (ES) have an immunomodulatory role in the wound healing process (van der Plas et al., 2007). Plas It has been reported that ES elastase in neutrophils helps to resolve the prolonged inflammatory response present in a chronic wound by inhibiting neutrophil migration by degrading the extracellular matrix (Bohova et al., 2012; van der Plas et al., 2007). The mentioned maggots belong to the common green bottle fly Lucilia sericata, Meigen which is one of the best known fly species found in many regions of the world. The advantages of MDT are its speed and efficiency in the removal of necrotic tissue and cellular debris in the wound bed (debridement), being a low‐cost treatment method, easy applicability and not requiring hospitalization. At the same time, the fact that chronic wounds can be treated and cleaned from infection without requiring oral or parenteral treatment (such as antibiotic treatments) for patients with systemic problems (such as diabetes) provides serious convenience for both the patient and the clinician (Fleischmann, 2004). Herbal treatment is another treatment method whose usability on chronic wound healing has been investigated (Naik & Harding, 2017). Some medicinal plants have been used in wound treatment since ancient times (Adetutu et al., 2011). In vivo studies on the treatment of dermatological disorders with different plants have shown promising results, especially on incisions, acute and chronic wounds, burn wounds (Firdous & Sautya, 2018; Jain et al., 2009; Mirmalek et al., 2016). According to WHO reports, approximately 80% of the population in developing countries use herbal treatment options for primary health care (WHO, 2005). Some plants belonging to the Asteraceae family have been used in folk medicine for wound healing for about a thousand years. Achillea, named after Achilles, one of the most important heroes of Greek Mythology, according to the legend, Achilles (Lat. Achil) treated his wounded soldiers during the Trojan War with Achillea millefolium L. (Cheers, 1999). Achillea L. (Asteraceae) extracts, which are extremely rich in phytochemical components, have valuable biological properties, especially when used as active ingredients in dermatological treatment and wound care products (Strzępek‐Gomółka et al., 2021). Wound healing activities of species such as A. millefolium L., A. kellalensis Boiss., Achillea biebersteinii Afan. and A. asiatica Serg. have been shown by in vivo studies (Akkol et al., 2011; Dorjsembe et al., 2017). In developing countries, Achillea species such as A. fragrantissima, (Eissa et al., 2018) A. millefolium L., (Mohammadhosseini et al., 2017) A. biebersteinii Afan., A. nobilis L., (Ghorbani, 2005) A. asiatica Serg. have been traditionally used in the treatment of wounds and inflammatory diseases (Eruygur et al., 2020). A. sintenisii Hub. Mor. is an endemic species distributed in Sivas and Erzincan provinces of Turkey, growing on steppes, calcareous slopes and gypsiferous hills. Phytochemical studies have reported that its flavanoids, especially flavanoids, promote collagen synthesis by increasing fibroblast proliferation and thus accelerate tissue repair, and the major components with potential for wound healing activity are quinic acid and chlorogenic acid (Eruygur et al., 2023). Considering the various biological activities reported, it has been suggested that Lucilia sericata larval secretions and Achillea sintenisii extracts may be useful in the treatment of diabetic wound healing. A detailed investigation of the favourable or unfavourable effect of the combined use of these therapeutic agents of plant and animal origin on the healing of a chronic wound may provide a database for the literature. The activation or inactivation of the treatment in terms of speed and duration, the effect of the synergistic or antisinergic effect of these two therapeutic agents on the healing process when used in combination in a chronic wound bed is a matter of curiosity. Therefore, in this study, the effects of sterile L. sericata maggot secretion extract and A. sintenisii above‐ground parts extract independently and in combination were investigated on an in vivo excisional wound model. MATERIALS AND METHODS Lucilia sericata culture The culture of Lucilia sericata flies cultivated under laboratory conditions was carried out at the ‘Maggot Research Laboratory’ located within the Çubuk GETAT Centre at Ankara Yıldırım Beyazıt University. The insectarium has a ventilation system where the light–dark photoperiod, humidity and temperature can be adjusted. Lucilia sericata pupae were turned into adults within 7–10 days in specially prepared 40 × 40 × 40 cm wire cages surrounded by tulle. Adult individuals were fed with 20% sugar water. Chicken livers were placed in petri dishes and left inside the cages to enable female flies to lay eggs. The eggs were collected from the hatching cages, separated and washed in distilled water to remove debris and non‐viable eggs. For sterilization, eggs were subjected to two rounds of 0.05% NaOCl treatment, each involving agitation with a vortex mixer (2000 rpm, 1 min per cycle), followed by careful removal of floating (non‐viable) eggs. Post‐sterilization, eggs were streaked onto nutrient‐agar plates and incubated at 37°C overnight to monitor for microbial contamination. Only batches with negative growth were released for clinical use. The examination of sterile larval development from eggs was conducted utilizing a stereo microscope (Olympus SZX10). Obtaining larval secretion Larvae nearing the end of their 1st instar or at the beginning of their 2nd larval instar are used in wound treatment. To obtain larval secretion, the techniques of Barnes and Gennard and Doğandemir were used (Barnes & Gennard, 2013; Doğandemir, 2010). A total of 2000–4000 sterilized larvae at the appropriate stage were carefully collected in 50 mL falcon tubes. Sterile larvae were incubated overnight at 25°C in test tubes containing distilled water. Then, this liquid, including larval secretions, was transferred to centrifuge tubes and centrifuged for 15 min. At the end of centrifugation, a liquid phase is obtained between the pellet and the solid layer on top. This liquid is withdrawn with a sterile syringe, passed through a 0.2 μm filter and used immediately. Collection and preparation of plant material Achillea sintenisii, which was selected as a phytotherapeutic species, was collected during the flowering period (2021‐June) from 1420 m southeast of the road junction of Hafik İnceağa village, Sivas (37 S 340045–4408104 Hamzaoğlu & Koç 3591). A herbarium sample of the plant was prepared and recorded in Ankara University, Faculty of Pharmacy Herbarium. (Herbarium number: 30920). The samples were dried and stored in a cool, shaded room. Obtaining extract from plant material and preparation of pomade from plant extract The above‐ground parts of Achillea sintenisii dried in the shade were pulverized with the help of a plant grinder. Fifty grams of the powdered sample was taken and subjected to extraction with 500 mL MeOH at room temperature for 1 h using ultrasonic bath. After extraction, the filtrate was filtered with filter paper and evaporated to dryness at 45°C under low pressure in a rotavapor. The weight of the extract was determined by weighing the weights of the flasks containing the extract and the tare of the flasks and taking the difference between them. The concentrated extract obtained at the end of the process was stored at 4°C. The extract stored at 4°C and a stock was prepared for use in treatment. The herbal sample 10 g of Achillea sintenisii extract, dissolved in 5 mL of 3% concentration Dimethylsulfoxide (DMSO) and added to 10 g of base cream. It was mixed until homogenized and the product was obtained in pomade form. It was mixed until homogenized and the product was obtained in pomade form. Animal experiment protocol The study was conducted on 52 male Wistar Albino rats weighing 200–300 g. Rats had free access to standard diet and water ad libitum. Rats were divided into 4 groups of 13 animals each. The rats were housed in standard laboratory balanced heat resistant rat cages in a quiet room of 15 square metres. The environment where the rats were kept at an average of temperature (21 ± 3)°C with air conditioning. The ambient humidity was kept between 45%–50% and they were fed with standard rat diets containing 15%–20% protein and their drinking water was changed twice a day. All rats were kept on a 12:12 h light/dark cycle. Each animal in each group was kept in sterile cages. All the procedures which applied to animals were carried out in accordance with ethical rules regarding the care and use of animals (Animal Experiments Local Ethics Committee Protocol Number: 610). Induction of diabetes All the rats were fasted overnight before administration of streptozotosin (STZ). STZ was administered at a dose rate 60 mg/kg, i.p. using a freshly prepared 0.1 M cold citrate buffer (pH 4.5). After 2 days of STZ injection, blood glucose level was monitored using glucometer. Rats with blood glucose levels more than 200 mg/dL were considered as diabetic and used for further study (Schmatz et al., 2009). In this context, 28 rats that developed complications and were not diabetic were excluded from the experiment and the study continued with the remaining rats. In addition, the blood glucose levels of the animals were monitored and checked at the middle and end of the study, and the study was continued with the animals whose diabetic status remained. Excisional wound modelling Rats were anaesthetised by intraperitoneal intramuscular administration of 10 mg/kg dose of xylazine HCl (Rompun, Bayer, Turkey) and 50 mg/kg dose of ketamine HCl (Ketalar, Warner Lambert Pharmaceuticals Industry and Trade Inc., Istanbul). Each group was placed in supine position, and the dorsal scalp was shaved with a shaver without damaging the skin; routine aseptic preparations were made in the area where the wound would be created. The wound area was wiped with 70% alcohol and then cleaned with povidone iodine solution in accordance with antisepsis rules. A circular area with a diameter of 1.5–2 cm was marked with pen, and a full‐thickness circular excisional wound was created in all four groups by means of a 6 mm diameter biopsy punch tool (Acu‐Punch) and surgical scissors, covering the skin, subcutaneous connective tissue and ‘panniculus carnosus’ layer. In order to observe the differences in the healing region of the wounds, a full‐thickness wound skin defect was created in the dorsal skin region of the rats in the groups based on the median line, cranial and caudal areas. The day the wound model was created was accepted as Day 0. Experimental treatments On the treatment days, it was imperative to meticulously calculate the dosage of the drugs given to the subjects in each group. The main objectives of the study were twofold: firstly, to eliminate the risk of side effects during the course of the experiment and secondly, to accurately assess the effect rates at the end of the experiment. To achieve this goal, it was necessary to perform precise conversion calculations to determine the exact doses of the therapeutic agent to be applied topically. DF (Diabetic Furacin) 0.2 g Furacin® commercial medical cream was applied topically to the wound area once daily for 12 days to the first group of experimental animals (n = 6). DM (Diabetic Maggot) 200 μL larval secretion was applied to the wound area by impregnating surgical sponges once daily for 12 days to the second group of experimental animals (n = 6). DA (Diabetic Achillea sintenisii ) cream prepared from 0.2 g Achillea sintenisii metonol extract was applied topically to the wound area once daily for 12 days to the third group of experimental animals (n = 6). DM + DA (Diabetic Maggot + Diabetic Achillea sintenisii) fourth group experimental animals were impregnated with 200 μL of Maggot (larva) secretion and the cream prepared from 0.2 g of Achillea sintenisii was applied to the wound area once daily for 12 days (n = 6). Monitoring of wound healing and collection of tissue samples Wound follow‐up was conducted on Days 0, 4 and 8. For histopathological examination on Day 12, wound biopsy samples were taken with 6 mm diameter biopsy punches. The tissue samples collected from the opened wounds were preserved in 10% neutral formalin. The wound healing of the rats in all four groups was photographed with a camera from a height of 15 cm on Days 0, 4, 8 and 12. Later on, the wound area was evaluated by using the AutoCAD program. Wound contraction was calculated as a percentage of the reduction in wounded area. Histopathological examination Preparation of the relevant wound samples for histopathological evaluations was carried out at Ankara Yıldırım Beyazıt University, Central Research Laboratory Application and Research Centre. Wound tissue samples were fixed in 10% neutral formalin for 1 week and then washed in tap water for 10 h and underwent routine tissue section follow‐up processes. Relevant wound tissues underwent dehydration with ascending grades of ethanol (70°, 80°, 90°, 96° and 100°) and xylene series to ensure transparency. Afterwards, the samples were embedded in paraffin in blocks. With a microtome (Leica RM2245), 6 μm sections were taken from the relevant paraffin samples to adhesive slides and stained with haematoxylin and eosin (H&E) dye, examined under a research microscope (Olympus® BX51) and photographed. Evaluation of histological changes was done for the presence of fibroblast, epithelization, collagen, angiogenesis, hair follicle in a scale of 0, 1, 2, 3, and 4 as absent, few, mild, moderate and marked, respectively. Statistical analysis The data on percentage wound healing was statistically analysed using one‐way analysis of variance (ANOVA). The values of p < 0.05 were considered statistically significant. RESULTS General and macroscopic results The study was conducted in diabetic rats only. Polydipsia, polyuria, polyphagia, weight loss, weakness and drowsiness were observed in all diabetic rats. When the healing rate of the cranial, median line and caudal wounds from which the wound biopsy material was taken on the 12th day of the subjects in the DF, DM, DA and DM + DA groups were evaluated, it was observed that the fastest and most effective healing occurred in the wound opened in the cranial region compared to the other regions. After the surgical procedure performed on the dorsal regions of the subjects in the four groups, infection development was observed only in 1 subject in the maggot (larva) group (DM) on the 5th day. Complications such as haematoma, serous fluid accumulation, subcutaneous pus formation or wound line dehiscence did not develop. It was determined that there were statistically significant differences between the macroscopic measurements in the wounds between the groups and the comparison of different days in each group (Figure 1, p < 0.05). The effect of Maggot secretion and Achillea sintenisii methanol extract on the evolution of a wound healing macroscopic wound healing examples on Days 0, 4, 8 and 12. Comparison of wound dimension measurements There is a statistically significant difference between the measurements of wounds in the DF, DM, DA and DM + DA groups on the 4th day, the 8th day and the 12th day (p = 0.01). There is a significant difference between the 12th day measurement averages of the wounds in the DF and DA groups and the DM and DM + DA groups, and the 12th day measurement average of the DF and DA group is higher than the DM and DM + DA groups (Table 1). TABLE 1Comparison of wound measurements (cm) according to time and groups.DayDFDMDADM + DA p * Mean ± SDMean ± SDMean ± SDMean ± SD01.87 ± 0.28Aa1.87 ± 0.11Aa1.84 ± 0.12Aa1.81 ± 0.12Aa0.9441.48 ± 0.31Aa1.09 ± 0.04Bb1.48 ± 0.12Aa1.26 ± 0.07Bc0.00181.07 ± 0.1Ba0.68 ± 0.18Cb0.93 ± 0.11Cc0.67 ± 0.06Bb0.001120.53 ± 0.04Ca0.36 ± 0.12Db0.37 ± 0.1Cb0.31 ± 0.17Db0.019 p ** 0.001000 Note: A, B, C, D; Differences between means with different letters in the same column are significant (p < 0.05). a, b, c, d: Differences between means with different letters in the same row are significant (p < 0.05).*Kruskal–Wallis statistical significance level for the difference between measurements in 4 groups at each time.**Friedman test significance level for the difference between measurements at 4 different times in each group. Comparison of wound measurements (cm) according to time and groups. Note: A, B, C, D; Differences between means with different letters in the same column are significant (p < 0.05). a, b, c, d: Differences between means with different letters in the same row are significant (p < 0.05). Kruskal–Wallis statistical significance level for the difference between measurements in 4 groups at each time. Friedman test significance level for the difference between measurements at 4 different times in each group. A significant difference was obtained between time measurements on Days 0, 4, 8 and 12 within each group (p = 0.01). Day 0 has the highest mean value and Day 12 has the lowest mean value, and the mean values decrease from 0 to 12 days (Table 1). Wound area and contraction results (%) The surface areas of the wounds created by punch biopsy were converted into numerical data with the help of millimetric paper on Days 0, 4, 8 and 12, and the wound surface areas were calculated and the healing rates in the groups were determined according to Day 0. There is no statistically significant difference between the groups in terms of wound area (cm2) levels (p = 0.284). There is a significant difference between the groups in terms of % contraction levels (p = 0.009). The % contraction levels of the DF group were lower than the DM, DA and DM + DA groups (Figure 2, Table 2). The difference in wound area and percentage contraction levels between the groups. TABLE 2ANOVA table for differences in wound area (cm2) and contraction (%) by groups.VariableGroupGroupANOVAMeanMin.MaksSS F p DifferenceTU Wound area (cm2)DF(1) 7.443.0711.233.061.2860.284‐DM(2) 5.911.5811.223.58DA(3) 6.512.1410.853.27DM + DA(4) 5.640.8211.143.81% ContractionDF(1) 45.0218.8072.6721.664.1310.009* 1 < 2 1 < 4 DM(2) 64.2540.4785.9216.85DA(3) 53.3626.4680.2821.76DM + DA(4) 65.8040.5892.6420.97Abbreviations: F, ANOVA test result; TU, Tukey test. Note: Superscripts 1, 2, 3, and 4 represent the DF, DM, DA, and DM + DA groups, respectively. The “>” and “<” symbols indicate which groups differ statistically according to the Tukey test results.* p < 0.05. ANOVA table for differences in wound area (cm2) and contraction (%) by groups. 1 < 2 1 < 4 Abbreviations: F, ANOVA test result; TU, Tukey test. Note: Superscripts 1, 2, 3, and 4 represent the DF, DM, DA, and DM + DA groups, respectively. The “>” and “<” symbols indicate which groups differ statistically according to the Tukey test results. p < 0.05. A significant difference was found between days in terms of wound area (cm2) levels (p = 0.001). Day 0 wound area levels were significantly higher than Days 4, 8 and 12 wound area levels; Day 4 wound area levels were significantly higher than Days 8 and 12 wound area levels and Day 8 wound area levels were significantly higher than Day 12 wound area levels. There is a significant difference between days in terms of % contraction levels (p = 0.001). Day 4 contraction levels were significantly lower than Days 8 and 12 contraction levels, and Day 8 contraction levels were significantly lower than Day 12 contraction levels (Figure 3, Table 3). The difference in wound area and percentage contraction levels between the days. TABLE 3ANOVA table for differences in wound area (cm2) and contraction (%) by days.VariableGroupDayANOVAMeanMin.MaksSS F p DifferenceTU Wound area (cm2)Day 0(1) 11.1110.8511.230.16511.90.001* 1 > 2,1 > 3 1 > 4,2 > 3 2 > 4,3 > 4 Day 4(2) 7.446.279.121.05Day 8(3) 4.933.966.540.97Day 12(4) 2.010.823.260.84% ContractionDay 0(1) ....169.30.001* 2 < 3 2 < 4,3 < 4 Day 4(2) 33.8218.8051.8110.68Day 8(3) 55.6141.7764.718.70Day 12(4) 81.9070.9892.647.53Abbreviations: F, ANOVA test result; TU, Tukey test. Note: Superscripts 1, 2, 3, and 4 represent days 0, 4, 8 and 12, respectively. The “>” and “<” symbols indicate which days differ statistically according to the Tukey test results.* p < 0.05. ANOVA table for differences in wound area (cm2) and contraction (%) by days. 1 > 2,1 > 3 1 > 4,2 > 3 2 > 4,3 > 4 2 < 3 2 < 4,3 < 4 Abbreviations: F, ANOVA test result; TU, Tukey test. Note: Superscripts 1, 2, 3, and 4 represent days 0, 4, 8 and 12, respectively. The “>” and “<” symbols indicate which days differ statistically according to the Tukey test results. p < 0.05. As expected, as the days progress, the wound areas become smaller and the percentage of contraction increases within the same group. At the end of the 12th day, it was observed that the order from least to most in terms of wound area and from most to least in terms of contraction percentage was DM + DA, DM, DA, DF (Figures 1 and 4). Percentage change in contraction across different days between groups graph. Histopathological results In all groups, epithelialization, fibrovascular connective tissue profiling, collagenization, angiogenesis and hair follicle development in the wound area were examined in histopathological examination (Figure 5). (a) Histological findings of the DF group at the end of the 12th day 100×. (b) Histological findings of the DM group at the end of the 12th day, 100×. (c) Histological findings of the DA group at the end of the 12th day 100×. (d) Histological findings of the DM + DA group at the end of the 12th day, 100×. e, epithelium; f, fibroblast; hd, hypodermis; k, collagen; kd, blood vessel; kf, hair follicle; kt, keratin. The histopathological levels evaluated on the 12th day of treatment groups are given in Table 4. When sections were evaluated in terms of epithelialization, fibrovascular connective tissue proliferation and collagenization, a statistically significant difference was observed among all groups by the 12th day (p < 0.05). TABLE 4Histological evaluation of wound healing level.DFDMDADM + DAEpithelialization2.41 ± 0.08a2.73 ± 0.11c2.58 ± 0.04b2.95 ± 0.09dFibroblasts2.90 ± 0.11a3.35 ± 0.07c3.12 ± 0.1b3.50 ± 0.07dCollagen2.73 ± 0.06a2.94 ± 0.03c2.86 ± 0.04b3.21 ± 0.12dAngiogenesis2.32 ± 0.11a2.6 ± 0.12b2.33 ± 0.08a2.87 ± 0.11cHair follicle0.69 ± 0.08a0.85 ± 0.05b0.7 ± 0.08a1.07 ± 0.14c Note: Values are mean + SD of 6 rats in each group. Significance at p < 0.05. Differences between means with different letters on the same row are significant. Histological evaluation of wound healing level. Note: Values are mean + SD of 6 rats in each group. Significance at p < 0.05. Differences between means with different letters on the same row are significant. It was observed that re‐epithelialization started in all groups and the highest statistical score was in DM + DA (group‐4), followed by group‐2 DM. Statistically similarity was found between group‐4 DM + DA and group‐2 DM. In both groups, it was observed that the regenerated epithelial layer consisted of more cells and the regenerated epithelium formed papillary extensions towards the dermis layer (Figure 5b,d). On the other hand, it was observed that macrophages did not show an attitude of reducing the number of fibroblast cells with the decrease of macrophages in the inflammatory phase for these two groups; on the contrary, proliferating fibroblast cells (fibrovascular connective tissue profiler) matured earlier. Fibroblast levels were significantly increased in DM (group‐2) and DM + DA (group‐4) compared to DF (group‐1) and DA (group‐3). It was found that collagen production was more controlled in DM + DA (group‐4) compared to the other treatment groups and the statistical scores were significant (Figure 5d, Table 4, p < 0.05). Angiogenesis scores of DM + DA (group‐4), in which new vessel proliferation was observed in the dermis layer, were found to be significant compared to the other treatment groups (Figure 5, Table 4, p < 0.05). In the evaluation, no significant difference was observed between the DF (group‐1) and DA (group‐3) in terms of angiogenesis and hair follicles (Figure 5a,c, Table 4, p < 0.05). The values are statistically higher in the DM group than in these two groups (Figure 5b, Table 4, p < 0.05). In the DM + DA (group‐4), the atrophic hair follicles extending from the newly formed epidermis were found to be statistically higher than the values in the other treatment groups (Figure 5d, Table 4, p < 0.05). The lowest scores were found in DF group‐1 and DA group‐3, respectively. When the sections were evaluated in terms of epithelialization, fibroblast and collagen, it was observed that there was a difference between all groups at the end of the 12th day. In all parameters, the highest values were measured in the DM + DA group (Table 4). DISCUSSION AND CONCLUSION Diabetic wounds represent a significant clinical problem in which the healing process is delayed due to pathological processes such as chronic inflammation, impaired angiogenesis and decreased cellular proliferation. Some plant‐based and animal‐derived therapeutic sources within the scope of ‘biological approaches’ are utilized by diabetic patients for the treatment of their wounds. There is insufficient research evidence demonstrating that most of these therapeutics promote healing of diabetic wounds. In this study, the effects of a combination of Lucilia sericata maggot secretions and Achillea sintenisii extracts on wound healing in diabetic rats were investigated histopathologically. According to the results obtained, the experimental groups treated with plant extract and maggot secretions exhibited a more rapid wound healing process compared to the untreated group, indicating that the combinations contributed to the wound healing process with a synergistic effect. This study presents significant findings that support the current literature regarding the use of naturally derived therapeutic agents in chronic wound treatment. In recent years, due to increasing antibiotic resistance and the limitations of conventional treatments, alternative approaches such as maggot debridement therapy and phytotherapy have garnered considerable attention in the scientific community. The results of our study elucidate the effect of these treatment modalities on the cellular mechanisms of wound healing, thereby filling gaps in the existing literature and opening new perspectives for future research. Furthermore, this study, which is based on the integration of both traditional knowledge and modern scientific approaches, has the potential to contribute to the development of evidence‐based, safe and cost‐effective treatment protocols in the field of translational medicine. The growing awareness of the clinical benefits of maggot (larva) therapy has led to a shift towards evidence‐based and targeted applications in the treatment of challenging wounds such as diabetic, venous and chronic pressure ulcers, as well as in reducing bacterial burden in these wounds. The wound healing properties of Lucilia sericata maggots and their secretions have been known for a considerable time. Maggots can stimulate wound healing by activating molecular processes in the wound area through excretion/secretion (ES) proteinases. Studies have demonstrated that ES possesses antibacterial, antifungal, anti‐inflammatory, angiogenic, proliferative, haemostatic and tissue‐regenerative effects both in vivo and in vitro. It has been proposed that these effects stimulate wound healing by initiating a direct signalling cascade with cells in the wound area and accelerate the wound healing process. Among the proteases found in L. sericata secretions are metalloproteases such as collagenase and serine, as well as proteases such as chymotrypsin‐like and trypsin‐like enzymes. Collagenase is one of the proteases belonging to the matrix metalloproteinase (MMP) family and potentially affects wound healing by playing a role in the remodelling of the extracellular matrix (ECM). Collagenase in ES catalyses chemical processes, accelerating proteolysis by breaking down tissue into smaller molecules and providing optimal conditions for regeneration through increased phagocytic activity and oxygenation following the removal of necrotic tissue. Thus, the ammonia and salts secreted by maggots in ES provide alkalinization of the wound environment for collagenase activity. Serine and aspartyl proteases assist wound healing and chemical debridement through proteolytic digestion and lyse dead and infected tissue through activity that breaks down extracellular matrix (ECM) proteins (Tombulturk & Kanigur‐Sultuybek, 2021). One of the most significant problems in diabetic wounds is that necrotic tissues provide a suitable environment for bacterial proliferation and impede wound healing. Therefore, in the treatment of diabetic wounds, debridement of necrotic tissue and deep cavities in the wound must be continued until granulation tissue forms. Compared to other debridement methods, maggot therapy is a preferable treatment option for patients because it debrides the wound by performing what is essentially microsurgery without damaging healthy tissue and is also less painful (Gazi et al., 2019). In treatment with maggot secretions, it has been reported and demonstrated through numerous clinical and experimental studies that debridement of necrotic tissues in wound tissue is accelerated, bacterial load is reduced and tissue regeneration is facilitated (Nigam et al., 2006; Sherman et al., 2000). It has been reported that treatment with secretions exhibits more effective and rapid antibacterial effects compared to existing techniques. In one study, a molecule named lucifensin was isolated for the first time from maggot secretions obtained from the intestines and tissues of larvae. Researchers indicated that this molecule could be used as an effective topical agent in the treatment of antibiotic‐resistant wounds. However, it is also emphasized that there are a limited number of randomized studies demonstrating antibacterial effects (Tombulturk & Kanigur‐Sultuybek, 2021). While it was initially thought that wound healing occurred solely through the debridement effect, it is now known that wound healing affects all four overlapping physiological phases (Mumcuoğlu, 2013). In particular, the molecular‐level effects of maggot secretions influence three fundamental processes that are critical to wound healing: inflammation, angiogenesis and cell migration/proliferation. Research is increasingly intensifying on the regularly structured nature of growth factor‐stimulating components in maggot secretion products against tissue damage and their regenerative response. Immune cells control inflammation by secreting cytokines and growth factors. In chronic wounds, this balance is disrupted and proinflammatory macrophages become dominant. Anti‐inflammatory macrophages, on the other hand, support cell proliferation and vessel formation by producing IL‐10, bFGF and VEGF. An in vitro study conducted with larval secretions demonstrated that these secretions suppressed proinflammatory cytokines (TNF‐α, IL‐12p40) and increased anti‐inflammatory IL‐10 production in a dose‐dependent manner (Tombulturk & Kanigur‐Sultuybek, 2021). In our study, it was observed that epithelialization was accelerated and inflammatory cell infiltration was reduced in the group treated with maggot secretions absorbed onto surgical sponges. As a result of their study evaluating the effects of maggot secretions on the functional activities of human neutrophils, van der Plas et al. (2007) discovered that maggot (larva) secretion therapy blocked multiple neutrophil inflammation‐promoting responses in chronic wounds in a dose‐dependent manner (van der Plas et al., 2007). Our assessment that larval secretions in the maggot treatment group prevent inflammation by facilitating the recruitment of neutrophils to the affected area to combat infection is consistent with the study findings of van der Plas et al. (2007). The rapidity and efficacy in epithelial regeneration result from keratinocytes facilitating their movement through their ability to phagocytose debris, tissue remnants, foreign bodies, bacteria and wound crusts that obstruct their path during migration. These findings support the anti‐inflammatory and tissue‐regenerative properties of maggot secretions. In a study conducted under in vitro conditions, the metabolic effects of maggot secretions on human neonatal fibroblast cultures were investigated. Following culture periods of 5 and 10 days, a marked increase in the number of intracellular organelle structures (specific ultrastructural components) and metabolic activities was observed in fibroblasts treated with secretions. The researchers proposed that this increase could be attributed to the elevation in the synthesis of extracellular matrix (ECM) components, particularly collagen (Polakovicova et al., 2015). According to the observational and macroscopic results in our in vivo experimental study, it was determined that as of Day 4, granulation tissue formation became prominent in parallel with the increase in fibroblasts in the treatment group to which we applied maggot secretions and that collagen became evident with angiogenesis accompanying the proliferation phase. Our findings demonstrated striking structural similarities with the findings of in vitro and in vivo studies conducted. These results strongly demonstrate the rapid efficacy of excretion/secretion therapy in chronic wound repair. Recent comprehensive research has focused on maggot excretion/secretion (ES), the isolation and characterization of beneficial enzymes for topical application in wound healing or the molecular mechanisms of these enzymes. Molecular and proteomic studies have demonstrated that L. sericata larval secretions possess three main components, including proteases, small antimicrobial peptides and growth factors (Tombulturk & Kanigur‐Sultuybek, 2021). Characterized angiopoietin‐1, collagenase‐1 (MMP‐1) with determined coding sequence, and chymotrypsin‐1 are proteinases known to potentially contribute to wound healing through debridement and tissue regeneration and have been recombinantly produced from L. sericata (Alipour et al., 2019, 2020). The recombinant production of enzymes secreted by L. sericata maggots holds great significance as an innovative and non‐invasive approach in the treatment of chronic ulcers, owing to their pathogenesis‐independent effects. Considering the broad potential for medical applications of collagenase, a method for the expression and purification of this enzyme has been developed for the first time through the cloning of the L. sericata collagenase (MMP‐1) gene into the SF9 insect cell line (Alipour et al., 2019). The findings obtained will contribute to the design of safe and versatile recombinant drugs in the future. Furthermore, secretions obtained from salivary glands are considered highly suitable candidate sources for the development of novel recombinant proteins that could be used in the treatment of pressure ulcers, burns, osteomyelitis, diabetic foot ulcers, cystic fibrosis and other chronic wounds. Similarly, medicinal plants aid the wound healing process, mainly owing to their antimicrobial, anti‐inflammatory and antioxidant properties (Builders & Builders, 2016). Historically, traditional medicinal plants have been used in various combinations to treat skin ailments and dermatological issues such as wounds, injuries, cuts, burns, alopecia and eczema (Li et al., 2022; Zeng et al., 2022). Achillea sintenisii, an endemic plant from the Asteraceae family, is recognized in traditional medicine for its wound healing and anti‐inflammatory effects. This species contains bioactive compounds like flavonoids, phenolic compounds and terpenoids, which demonstrate antioxidant and antimicrobial activities (Akkol et al., 2011; Konyalιoğlu et al., 2005). Recent studies have identified chlorogenic acid and quinic acid as the primary components involved in wound healing (Eruygur et al., 2023). Collagen, one of the main components of the extracellular matrix (ECM), plays a critical role in ensuring structural integrity by reconstructing degraded tissues. Fibroblasts are crucial for collagen accumulation (Suvik & Effendy, 2012). During the early proliferative phase, the activity of fibroblast cells involves cellular replication and migration to the wound area in response to signals from macrophages. On the third day of the healing process, fibroblasts that sense tension in the wound area regulate the synthesis and remodelling of high amounts of collagen, which determines wound healing activity in injured tissues (Panwar et al., 2013). Our results from Day 4 onwards demonstrated that A. sintenisii extract strongly stimulated fibroblast production. These results reveal the supportive role of A. sintenisii in the tissue repair process. In the present study, it was observed that independent topical applications of L. sericata maggot secretions and A. sintenisii extracts activated wound healing. It is noteworthy that their combination activated wound healing at an earlier stage in terms of speed and efficacy, suggesting a synergistic effect. The microscopic and macroscopic data obtained are consistent with in vivo studies by Gazi et al. (2019) and Nigam et al. (2022), which demonstrated the wound healing potential of maggot secretions in diabetic chronic wounds (Gazi et al., 2019; Nigam et al., 2022), as well as studies by Akkol et al. (2011), Uyar et al. (2017), and Almuhanna et al. (2023), which evidenced the wound healing activity of Achillea species extracts in diabetic chronic wounds (Akkol et al., 2011; Almuhanna et al., 2023; Uyar et al., 2017). Histopathological findings revealed that the combination of both biological agents led to faster and more effective epithelialization, increased fibroblast proliferation, enhanced collagen synthesis, matrix reorganization, angiogenesis and a significant reduction in inflammatory cell infiltration. These findings align with other studies in the literature on the activity of maggot secretions and A. sintenisii extracts in the wound repair process. For example, maggot therapy has been reported to accelerate granulation tissue formation and improve collagen organization in the wound area (Pritchard & Nigam, 2013). Similarly, A. sintenisii extracts have been suggested to have therapeutic potential in various pathological conditions related to oxidative stress, hyaluronidase inhibition, collagen synthesis or inflammation due to their valuable pharmacological activities (Anlas et al., 2023). This suggests that the debridement and antimicrobial effects of maggot secretions, combined with the antioxidant and tissue‐regenerative properties of phytotherapeutic extracts, may more effectively support the wound healing process. In conclusion, the wound healing process evaluated in this study showed that wounds in rats treated with L. sericata maggot secretions and/or A. sintenisii extract healed in a shorter time compared to those treated with Furacin, a commonly used wound healing agent. Moreover, the groups treated with both maggot and A. sintenisii extract exhibited better epithelial regeneration, collagenization and fibrovascular tissue proliferation. Ultimately, the combination of L. sericata maggot secretions and A. sintenisii extract may be an effective strategy for healing diabetic wounds. This study is the first report in the literature investigating the wound healing activities of combined animal and plant therapeutic agents in chronic diabetic wounds. However, larger‐scale and long‐term studies are needed for clinical applications. Additionally, elucidating the molecular mechanisms of this combination could contribute to optimizing treatment protocols. AUTHOR CONTRIBUTIONS Nevra Polat: Writing – original draft; writing – review and editing; methodology; formal analysis. Salih Mollahaliloğlu: Visualization; investigation. Murat Koç: Methodology; investigation; visualization; writing – review and editing. CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. ETHICS STATEMENT This experimental research has been done following the guideline of the local ethics committee. All the procedures which applied to animals were carried out in accordance with ethical rules regarding the care and use of animals (Animal Experiments Local Ethics Committee Protocol Number: 610). ACKNOWLEDGEMENTS This publication is based on the corresponding author's PhD thesis after graduation from YÖK 100/2000 priority PhD program. The author is grateful to the YÖK 100/2000 Scholarship PhD program for the opportunities provided. Polat, N. , Mollahaliloğlu, S. & Koç, M. (2026) Histopathological investigation of wound healing activities of Lucilia sericata Larva and Achillea sintenisii extract combinations in diabetic rat wound model. Medical and Veterinary Entomology, 40(3), 659–671. Available from: 10.1111/mve.70075 [Correction added on 8 June 2026 after first online publication: The Acknowledgements section has been updated and the Informed Consent section has been deleted.] Associate Editor: Zanthé Kotzé DATA AVAILABILITY STATEMENT The raw data used to prepare this manuscript are accessible in the Dryad repository at https://doi.org/10.5061/dryad.b2rbnzsv8 (Polat et al., 2025). REFERENCES Associated Data Data Availability Statement The raw data used to prepare this manuscript are accessible in the Dryad repository at https://doi.org/10.5061/dryad.b2rbnzsv8 (Polat et al., 2025).